Polymorphic OCT1: a valid biomarker, but for which drugs?

Author: Brockmöller Jürgen   Tzvetkov Mladen V  

Publisher: Future Medicine

ISSN: 1462-2416

Source: Pharmacogenomics, Vol.14, Iss.16, 2013-12, pp. : 1933-1936

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next